1 Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
2 We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure the right information is available in a timely manner while maintaining the highest standards of data integrity, confidentiality, and security These duties of HIM professionals are consistently found in coordinating a clinical study
3 A clinical study involves research using human volunteers (participants) that is intended to add to medical knowledge related to the treatment, diagnosis, and prevention of diseases or conditions.
4 Some reasons for conducting clinical studies include: Evaluating one or more interventions (drugs, medical devices, surgery, radiation therapy) for treating a disease, syndrome or condition Finding ways to prevent the initial development or recurrence of a disease or condition (medicines, vaccines, lifestyle changes) Evaluating interventions that could identify or diagnose a particular disease or condition Examining methods for identifying a condition or the risk factors for that condition Exploring and measuring ways to improve the quality of life through supportive care for people with a chronic illness
5 There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies
6 In a clinical trial, participants receive specific interventions according to the research plan or protocol created by the investigators or sponsors. Interventions may include medical products, such as drugs or devices; procedures; or changes to participants' behavior, such as diet. Clinical trials may compare a new medical approach to 1) a standard one that is already available, 2) to a placebo that contains no active ingredients, or 3) to no intervention.
7 When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives. The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators give a treatment to participants who have high blood pressure to see whether their blood pressure increases or decreases. Clinical trials used in drug development are described by phases as defined by the Food and Drug Administration (FDA).
8 Phase I: Researchers test a new drug or treatment in a small group of people for the first time to evaluate safety, determine a safe dosage range, and identify side effects. Phase II: The drug or treatment is given to a larger group to see if it is effective and to further evaluate its safety. Phase III: The drug or treatment is given to large groups to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
9 Screening Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Trial of Fulvestrant (Faslodex ) With or Without PD Palbociclib)± Goserelin in Women with Hormone Receptor-Positive, HER2- Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy - Pfizer (A ) Randomization Palbociclib + Fulvestrant End of Treatment Follow-up Placebo + Fulvestrant
10 Committee: Breast Cancer Sponsor: Pfizer and Parexel (CRO) Status: Closed to Enrollment Sponsor accrual target: 417 USON accrual target: 44 Consented & Registered: 25 Currently 6 Active & 12 Follow-up Patients 8 Principle Investigators/Sites 2 Protocol Amendments 5 ICF Revisions 27 Deviations 6 Serious Adverse Events (None Related to Study Rx)
11 In an observational study, investigators assess health outcomes by comparing subjects against a control group in cases where the investigator has no control over the experiment. Types of Observational studies: Case-control study Cross-sectional study Longitudinal study Cohort study Ecological study Participants may receive interventions or procedures as part of their routine medical care, but participants are not assigned to specific interventions by the investigator (as in a clinical trial).
12 Main purpose - collect information on patients treated for metastatic breast cancer, and their response to the various treatments for this disease. The investigator will provide information about patient s history of metastatic breast cancer, results of tests done for cancer, and past treatments. Every 3 months, the investigator will provide Genentech with information about ongoing treatment, results of tests, responses to treatment, and any complications. Total study duration - 8 years.
13 Committee: Breast Cancer Sponsor: Genentech & PPD Status: Open to Enrollment Sponsor accrual target: 1000 USON accrual target: 60 Consented & Registered: 48 Currently 45 Active & 0 Follow-up Patients 12 Principle Investigators/Sites No Protocol Amendments or ICF Revisions 14 Deviations 7 Serious Adverse Events (None Related)
14 Like Health Information Management, patient safety and protection are the highest priorities in clinical trials. Every research study must follow a rigorous review and oversight process. Clinical trials are regulated and monitored by independent committees and federal agencies to ensure the study is safe and scientifically relevant. Informed consent is an ongoing process designed to protect the rights and safety of people participating in clinical trials. Participants may stop participating in a clinical trial at any time for any personal or medical reason, and they will continue to receive all necessary standard medical care.
15 Created in 1974 by The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research Identify the basic ethical principles and develop guidelines for research involving human subjects. Respect for Persons Beneficence Justice Primary areas of application: (i) the boundaries between biomedical and behavioral research, (ii) assessment of risk-benefit criteria, (iii) appropriate guidelines for the selection of subjects and (iv) the nature and definition of informed consent
16 Good clinical practice (GCP) is an international quality standard provided by The International Conference on Harmonisation (ICH), an international body that defines standards for clinical trials. Tight guidelines on ethical aspects of a clinical study are strictly enforced. High standards are required in terms of comprehensive documentation for the clinical protocol, record keeping, training, and facilities. Quality assurance inspections ensure that these standards are achieved. Protection of human rights for subjects and volunteers in a clinical trial. It also provides assurance of safety and efficacy of the newly developed compounds. Standards on how to conduct clinical trials and define the roles and responsibilities of sponsors, investigators, and monitors.
17 Informed consent is a process providing potential and enrolled participants with information about a clinical study. This information helps people decide whether they want to enroll or continue in the study. The informed consent process is intended to protect participants and should provide enough information for a person to understand risks, benefits, and alternatives to the study. A person must sign an informed consent document before joining a study to show that he or she was given information on risks, potential benefits, and alternatives and understands it. Signing the document and providing consent is not a contract. Participants may withdraw from a study at any time.
18 Each federally supported or conducted clinical study and each study of a drug, biological product, or medical device regulated by the FDA must be reviewed, approved, and monitored by an institutional review board (IRB). The IRB s role is to make sure that the study is ethical and that the rights and welfare of participants are protected. Various Federal agencies, including the Office of Human Subjects Research Protection and the FDA, have the authority to determine whether sponsors of certain clinical studies are adequately protecting research participants.
19 According to FDA regulations, an Institutional Review Board (IRB) is a group formally designated to review and monitor biomedical research involving human subjects. An IRB has the authority to approve, require modifications in, or disapprove research. The IRB review serves an important role in the protection of the rights and welfare of human research subjects.
20 The purpose of IRB review is to assure, both initially in advance and by continuing periodic review, that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in research. To accomplish this purpose, IRBs use a group process to review research protocols and related materials (informed consent documents, investigator brochures, protocol amendments) to ensure protection of the rights and welfare of human subjects of research.
21 2 Boards Dallas 10 members Houston 9 members 2 types of Meetings Weekly Expedited meetings Monthly Full Board meetings A quorum must be established to begin the FB meeting. A quorum is one more than half members present, and one must be a nonscientific member. Oncologist (Chair) (S) Biostatistician (S) Nurse (S) Bioethics writer (S) Pharmacist (S) Attorney (NS) Chaplain (NS)
22 Houston Dallas
23 The IRB Coordinator primarily acts as a liaison between the IRB Committees and the Study Investigators or the sponsors via the Regulatory Affairs Department. The IRB Coordinator, under the direct supervision of the IRB Manager provides operational support, promotes ethical education and facilitates the functions of the IRB Committees.
24 Initial and on-going training of IRB Committee members Review, modify and retain IRB SOPs and IRB Coordinator manuals Prepare and complete Committee annual reports Review and process of all submissions for IRB meetings Coordinate IRB meeting plans and teleconferencing needs Prepare meeting activities including: meeting agendas, member packets, meeting minutes, invoices, etc.
25 Track the approval of regulatory submissions reviewed Post communications on the database management in CTMS Prepare renewal schedules and submission deadlines Prepare and maintain local and off-site storage Facilitate internal audits for process improvement Provide IRB education and mentorship to IRB, Regulatory Staff, site Investigators and research staff regarding IRB policies and procedures.
26 Provide guidance to research site personnel and research central operations on regulatory affairs requirements and procedures. Review, analyze and amend study Informed Consent Forms and study Protocols. Maintain critical trial deadlines with sites and sponsors Request and maintain sponsor required documents s, FDQs, PSPs, IB Signature Pages. Index critical trial documents into ImageNow, our electronic storage and maintenance system
27 Coordinate visits for Monitors and provide them with access to trial documents for periodic review (Remote or on-site) Submit and obtain IRB approval and renewal of clinical protocols, IDBs, ICFs and other items required by IRB, trial sponsor or FDA Collect, review and process Serious Adverse Events, Drug Brochures and Investigational New Drug Safety Reports Maintain updated Investigator and Pharmacy CVs, MLs, DORs and Laboratory Ranges and CLIAs Coordinate new USO staff on-boarding, orientation and training Prepare projects and facilitate FDA and/or Sponsor audits
28 Trial flips to Priority and Informed Consent is written Internal Consent review by Sr. Regulatory Specialist Consent review by Sponsor, PM, SI & Finance Study is submitted to IRB Protocol ICF Investigational Drug Brochure (IDB) Patient Materials (Advertisement, Educational, Recruitment) USOR Scientific Committee Review Form SI CV & Medical License List of Principle Investigators
29 FDQ Collection 3 week deadline 1572/DRAP/PSP/IDB Page 2 week deadline IRB Meeting/PI Approval Send complete packs to sponsor Sponsor review/resolve outstanding documents Sponsor gives regulatory approval, PM opens site to study
30 Submission to IRB Collection reminder Reminder Reminder Reminder Week Consent Trial Review "flips" to (Sponsor Priority, SI, PM, Status Finance) FDQ Collection 1572 DRAP collection Sponsor review and approval of Regulatory documents Consen t written / Internal Review Calls with sponsor to resolve outstanding items TPR IRB Meeting / PI Approval Packs ship to sponsor
31 Project Manager (Clinical Trial Manager) Site Services Quality Assurance Finance/Budget Contracts/Legal Privacy and Safety Biomedical Writers Billing and AR Health Informatics IPC Distribution IT/ CTMS support
32 Pharmaceutical companies (Sponsors) Pfizer Genetech Contract Research Organizations (CROs) Parexel Quintiles Site Maintenance Organization (SMO) Physician offices Hospitals Universities research and education Medical device companies
33 The foundation of Clinical Research and Health Information Management strongly resemble one another Ensure that participant information is secure and protected Improve healthcare quality, reduce errors, and advance knowledge surrounding cancer treatment Provide appropriate information to help guide medical decisions at the time and place of care Improve the coordination of care and information among hospitals, labs, physician offices, pharma companies and other entities for secure exchange of cancer care information. Promote early detection, prevention, and management of cancer or chronic diseases Collect complete and accurate documents in a timely manner for clinical trials to ensure the best treatment decisions
34 E-signatures for investigator trial documents Immediate processing by the regulatory team Faster approval from the sponsor Automatic storage in ImageNow Guaranteed legibility Accuracy and completeness Electronic IRB submissions Electronic storage Accuracy and completeness More studies submitted and approved
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: firstname.lastname@example.org Education: Masters of Science, Healthcare Administration, Capital City University,
volunteering for a clinical trial www.centerwatch.com :: about this pamphlet This pamphlet provides an overview of the clinical trials process and answers frequently asked questions that many potential
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
For more infomation about Cancer Clinical Trials at Upstate Cancer Center please call Upstate Connect 1.800.464.8668 TAKING PART IN CANCER TREATMENT RESEARCH STUDIES Information provided by: National Cancer
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
The Beginner Research Assistant/Coordinator (CRC) Track Basic Level Who: Clinical Research Assistant (CRA) CRC I This track was designed for the CRA/CRC I with less than 2 years of clinical research experience.
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion
Investigator Responsibilities Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 010 Version number: 1 Effective date: 01 June 2010 Review due: May 2011
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If
9.0 Protocol Violations, Deviations, and Exceptions 9.1 Definitions Protocol deviation(s): means a minor or administrative departure from the IRBapproved protocol procedures (e.g., the protocol, informed
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
The Clinical Trial Protocol Guide 2011 BioStrategics Consulting Ltd. BioStrategics Consulting Ltd THE CLINICAL TRIAL PROTOCOL The clinical trial protocol to test one s product, to confirm or reject a specific
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health
Josephine Silvestre, RN, MSN The University of Chicago Medical Center October 13, 2007 A study in which people participate as volunteers. A clinical trial is conducted to develop potential new treatments
Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA 1572) U.S. Department of Health and Human Services Food and Drug
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within
A Greater Understanding A Practical Guide to Clinical Trials Solving Insurance and Healthcare AccessProblems I since 1996 A Greater Understanding Patient Advocate Foundation MISSION STATEMENT Patient Advocate
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus November
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II We have no financial relationships
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
Operational aspects of a clinical trial Carlo Tomino Pharm.D. Coordinator Pre-authorization Department Head of Research and Clinical Trial Italian Medicines Agency Mwanza (Tanzania), June 11, 2012 1 Declaration
Good Clinical Practice and Regulatory Aspects Nora Espiritu MD, MPh, PhD (c) Former Executive Director of Research and Technology Transfer. Peruvian National Institute t of Health. Member of the Ethics
Advancing research: a physician s guide to clinical trials Recruiting and retaining trial participants is one of the greatest obstacles to developing the next generation of Alzheimer s treatments Alzheimer
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
Webcast Perspectives on Patient Recruitment Sponsors: Presenters Moderator: Christiane Truelove Editor in Chief, R&D Directions Chris.Truelove@ubm.com Speakers: Dr. Bradley Vince, D.O., President and Medical
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health This booklet is for people with cancer, their family,
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,
A Participant s Guide to Mental Health Clinical Research Contents Purpose of this document... 1 What is clinical research?... 2 Why do people choose to participate in research?... 3 What are the different
CLINICAL RESEARCH PROTOCOL CHECKLIST [taken from ICH GCP : Guidance for Industry, Good Clinical Practice: Consolidated Guidance, Revision 1 (R1) June 1996] ICH GCP, Section 6. CLINICAL TRIAL PROTOCOL AND
Glossary of Clinical Trial Terms ADVERSE REACTION: (Adverse Event): Also known as side effects, adverse reactions include any undesired actions or effects of the experimental drug or treatment. Experimental
Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors
Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE Jean Toth-Allen, Ph.D. Biophysicist Office of Good Clinical Practice Office of the Commissioner May 14, 2012 1 Overview I. Background why we are
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
Public Policy Statement: Clinical Trial Ethics Purpose As a global healthcare company, Merck's role is first and foremost to discover, develop and provide innovative products and services that save and
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
PrinciPles on Conduct of clinical Trials Communication of clinical Trial results Table of Contents Preamble...1 Commitment to Protecting Research Participants...5 Conduct of Clinical Trials...7 Ensuring
UNDERSTANDING LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 TABLE OF CONTENTS INTRODUCTION TO CLINICAL TRIALS What Is a Clinical Trial?...4 Types of Clinical
CLINICAL CASE STUDY SERIES Quality Management in Clinical Trials Clinical trials are conducted to collect the data necessary to provide information for academia, industry, and regulators to make decisions
UK Implementation of the EU Clinical Trial Directive 2001/20/EC: GCP Aspects. Dr. Colin Wilsher, FRQA. BARQA GCP Committee Chairman; & Pfizer Worldwide Development Quality Assurance. GIQAR, Roma, October
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL #  [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Objectives Guidelines suggest that following the good clinical research practice of monitoring/auditing
A Practical Guide on Applying USF HRPP P&Ps in the Clinical Setting Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research Learning Objectives Recognize the
Overview NIH policy requiring independent data and safety monitoring boards (DSMB) for all multicenter Phase III trials has existed since 1979; the most recent restatement was issued in 1998 (NIH Policy
IRB POLICY ON HUMAN RESEARCH PROTECTION (HRP) AND GOOD CLINICAL PRACTICE (GCP) TRAINING Collaborative Institutional Training Initiative (CITI) Requirements at Adventist Healthcare, Inc. I. Required Human
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
Awad Mohamed Ahmed, MD Professor of Medicine, University of Bahr Elghazal, Khartoum, Sudan For correspondence Professor Awad Mohamed Ahmed E-mail: email@example.com Tel.: +249 912344936 Abstract Randomized
Clinical Trials: Questions and Answers Key Points Clinical trials are research studies that test how well new medical approaches work in people (see Question 1). Every clinical trial has a protocol, which
NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of
Objectives Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Guidelines suggest that following the good clinical research practice of monitoring/auditing
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 1. Introduction The St. Michael s Hospital (SMH) REB
L1 2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager,
Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada: Clinical Trial Inspection Planning GCP Information Sessions November 2010 Overview GCP Inspection Target